Biomedicines,
Год журнала:
2024,
Номер
13(1), С. 47 - 47
Опубликована: Дек. 28, 2024
Gastrointestinal
tumors
present
a
significant
challenge
for
precision
medicine
due
to
their
complexity,
necessitating
the
development
of
more
specific
diagnostic
tools
and
therapeutic
agents.
Recent
advances
have
positioned
coding
non-coding
RNAs
as
emerging
biomarkers
these
malignancies,
detectable
by
liquid
biopsies,
innovative
Many
RNA-based
therapeutics,
such
small
interfering
RNA
(siRNA)
antisense
oligonucleotides
(ASO),
entered
clinical
trials
or
are
available
on
market.
This
review
provides
narrative
examination
potential
in
gastrointestinal
cancers,
with
an
emphasis
its
application
medicine.
discusses
current
challenges,
drug
resistance
tumor
metastasis,
highlights
how
molecules
can
be
leveraged
targeted
detection
treatment.
Additionally,
this
categorizes
targets
based
tissue
type,
offering
comprehensive
analysis
role
advancing
tumors.
Efficient
delivery
of
siRNA-based
polyplexes
to
tumors
remains
a
major
challenge.
Nonspecific
interactions
in
the
bloodstream,
limited
circulation
time,
and
nontargeted
biodistribution
hamper
sufficient
tumor
accumulation.
To
address
these
challenges,
we
developed
an
ionic
hyaluronic
acid
(HA)
coating
shield
sequence-defined
oligoaminoamide-based
polyplexes.
This
should
positive
polyplex
surface
charge,
thus
reducing
nonspecific
enhancing
serum
stability.
Additionally,
modified
HA
with
cyclic
RGDfK
(cRGD)
peptide
specifically
target
endothelial
cells
(TECs).
Optionally,
polyethylene
glycol
(PEG)
spacer
was
also
introduced
improve
ligand
presentation
on
surface.
The
HA-coated
exhibited
favorable
physicochemical
properties,
including
negative
zeta
potential
effective
siRNA
retention
within
polyplex,
which
not
adversely
affected
by
PEG
or
cRGD
modification.
In
vitro
analyses
revealed
that
only
enhanced
cell
association
preserved
high
transfection
efficiency
plain
cationic
but
coating-dependent
cellular
internalization,
as
evidenced
competitive
inhibition
experiment.
Even
presence
serum,
encapsulated
effectively,
suitable
particle
sizes,
maintained
gene
silencing
efficiency.
vivo
studies
involving
intravenous
administration
into
Neuro2a
tumor-bearing
mice
showed
coating,
particularly
when
cRGD,
significantly
increased
accumulation
HA–PEG–cRGD-shielded
compared
Collectively,
our
results
indicate
superior
performance
terms
stability
uptake,
both
vivo.
Gels,
Год журнала:
2025,
Номер
11(5), С. 367 - 367
Опубликована: Май 17, 2025
This
study
reports
the
development
of
peptide-based
hydrogels
for
encapsulation
and
controlled
release
peptide
nucleic
acids
in
drug
delivery
applications.
Ultrashort
aromatic
peptides,
such
as
Fmoc-FF,
self-assemble
into
biocompatible
with
nanostructured
architectures.
The
functionalization
tripeptides
(Fmoc-FFK
Fmoc-FFC)
lysine
(K)
or
cysteine
(C)
enables
electrostatic
covalent
interactions
model
PNAs
engineered
glutamic
acid
residues,
respectively.
Hydrogels
were
polymerized
situ
presence
PNAs,
component
ratios
systematically
varied
to
optimize
mechanical
properties,
loading
efficiency,
kinetics.
formulations
obtained
a
1/10
ratio
Fmoc-FF(K
C)/Fmoc-FF
provided
an
optimal
balance
between
structural
integrity
performance.
All
hydrogel
demonstrated
high
stiffness
(G′
>
19,000
Pa),
excellent
water
retention,
minimal
swelling
under
physiological
conditions
(ΔW
<
4%).
studies
over
10
days
showed
that
enabled
faster
higher
(up
90%),
while
bonding
resulted
slower,
sustained
(~15%).
These
findings
highlight
tunability
system
diverse
therapeutic
Frontiers in Drug Delivery,
Год журнала:
2024,
Номер
4
Опубликована: Авг. 15, 2024
RNA
therapy
is
a
rapidly
expanding
field
and
has
great
promise
in
achieving
targeted
gene
silencing
contributing
to
personalized
medicine.
However,
the
delivery
of
molecules
into
organs
or
cells
still
challenging.
To
overcome
this
hurdle,
number
nanocarriers
with
pros
cons
have
been
developed.
This
study
was
designed
develop
simple
cost-effective
approach
functionalize
biodegradable
magnetic
iron
nanoparticles
(MNPs)
for
cell-specific
siRNA
delivery.
MNPs
were
synthesized
based
on
co-precipitation
further
functionalized
sodium
citrate
polyethyleneimine
(PEI)
followed
by
material
characterization
using
TEM,
FTIR,
Zeta
potential.
The
PEI-coated
conjugated
CD31
antibody
complexed
linker-free
approach.
siRNA-loaded
successfully
knocked
down
expression
GAPDH
human
endothelial
(ECs)
NOTCH3
vascular
smooth
muscle
(VSMCs).
In
an
EC
VSMC
co-culture
system
under
shear
stress
mimic
blood
flow,
specifically
delivered
ECs.
Our
represents
versatile
platform
that
could
be
adopted
general
Biomacromolecules,
Год журнала:
2024,
Номер
unknown
Опубликована: Сен. 26, 2024
Quinine-based
polymers
have
previously
demonstrated
promising
performance
in
delivering
pDNA
cells
owing
to
their
electrostatic
as
well
the
nonelectrostatic
interactions
with
pDNA.
Herein,
we
evaluate
whether
quinine-based
are
versatile
for
delivery
of
mRNA
and
Cas9-sgRNA
complexes,
especially
a
serum-rich
environment.
Both
complex
potent
therapeutics
that
structurally,
chemically,
functionally
very
different
from
By
exploring
family
7
vary
monomer
structure
polymer
composition,
tested
numerous
formulations
(42
pDNA,
96
mRNA,
48
Cas9-sgRNA)
payload-polymer
complexation
compare
payload-dependent
structure-activity
relationships.
Several
comparable
or
better
than
commercially
available
transfection
agent
jetPEI.
The
results
this
study
demonstrate
potential
carrier
platform
wide
range
nucleic
acid
serving
drug
needs
field
genetic
medicine.
Pharmaceutics,
Год журнала:
2024,
Номер
16(8), С. 1028 - 1028
Опубликована: Авг. 1, 2024
Immunotherapy
combats
tumors
by
enhancing
the
body's
immune
surveillance
and
clearance
of
tumor
cells.
Various
nucleic
acid
drugs
can
be
used
in
immunotherapy,
such
as
DNA
expressing
cytokines,
mRNA
vaccines,
small
interfering
RNAs
(siRNA)
knocking
down
immunosuppressive
molecules,
oligonucleotides
that
adjuvants.
Nucleic
drugs,
which
are
prone
to
nuclease
degradation
circulation
find
it
difficult
enter
target
cells,
typically
necessitate
developing
appropriate
vectors
for
effective
vivo
delivery.
Biomimetic
drug
delivery
systems,
derived
from
viruses,
bacteria,
protect
cargos
clearance,
deliver
them
cells
ensure
safety.
Moreover,
they
activate
system
through
their
endogenous
activities
active
components,
thereby
improving
efficacy
antitumor
immunotherapeutic
drugs.
In
this
review,
biomimetic
systems
relieving
a
microenvironment
introduced.
Their
activation
mechanisms,
including
upregulating
proinflammatory
serving
inhibiting
checkpoints,
modulating
intratumoral
elaborated.
The
advantages
disadvantages,
well
possible
directions
clinical
translation,
summarized
at
last.